NASDAQ: CURX
Curanex Pharmaceuticals Inc Stock Ownership - Who owns Curanex Pharmaceuticals?

Insider buying vs selling

Have Curanex Pharmaceuticals Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when CURX insiders and whales buy or sell their stock.

CURX Shareholders

What type of owners hold Curanex Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Chang Liu3.82%1,082,200$330.07kInsider
Dian Ying Jing2.43%690,000$210.45kInsider
Jun Liu2.43%690,000$210.45kInsider
Geode Capital Management LLC0.39%111,130$33.89kInstitution
Two Sigma Securities LLC0.20%56,651$17.28kInstitution
Xtx Topco Ltd0.18%51,289$15.64kInstitution
Citadel Advisors LLC0.18%50,559$15.42kInstitution
Two Sigma Investments LP0.07%20,254$6.18kInstitution
Citigroup Inc0.07%19,332$5.90kInstitution
Jump Financial LLC0.04%10,551$3.22kInstitution

1 of 2

CURX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CURX1.16%8.68%
BCDA0.35%99.65%Net BuyingNet Buying
KAPA2.81%35.51%
APRE3.64%96.36%Net Buying
IMRN0.03%1.91%

Curanex Pharmaceuticals Stock Ownership FAQ

Who owns Curanex Pharmaceuticals?

Curanex Pharmaceuticals (NASDAQ: CURX) is owned by 1.16% institutional shareholders, 8.68% Curanex Pharmaceuticals insiders, and 90.16% retail investors. Chang Liu is the largest individual Curanex Pharmaceuticals shareholder, owning 1.08M shares representing 3.82% of the company. Chang Liu's Curanex Pharmaceuticals shares are currently valued at $352.80k.

If you're new to stock investing, here's how to buy Curanex Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.